Shuangshuang Lu - Search Results

Year	Number of Results
2010	1
2011	1
2012	2
2013	3
2014	3
2015	2
2016	1
2017	4
2018	2
2019	3
2020	7
2021	13
2022	14
2023	8
2024	3

1

Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer.

Cao D, Song Q, Li J, Jiang Y, Wang Z, Lu S. Cao D, et al. Among authors: lu s. Expert Rev Mol Med. 2021 Dec 15;23:e21. doi: 10.1017/erm.2021.26. Expert Rev Mol Med. 2021. PMID: 34906271 Review.

2

Is It a "Colon Perforation"? A Case Report and Review of the Literature.

Lu S, Yao X, Shi J, Huang J, Zhuang S, Ma J, Liu Y, Zhang W, Yu L, Zhu P, Zhu Q, Shi R, Zheng H, Shao D, Pan Y, Bao S, Qin L, Huang L, Liu W, Huang J. Lu S, et al. Front Med (Lausanne). 2022 Mar 10;9:817029. doi: 10.3389/fmed.2022.817029. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35360735 Free PMC article. Review.

3

Evaluation of animal models of Crohn's disease with anal fistula (Review).

Lu S, Zhu K, Guo Y, Wang E, Huang J. Lu S, et al. Exp Ther Med. 2021 Sep;22(3):974. doi: 10.3892/etm.2021.10406. Epub 2021 Jul 8. Exp Ther Med. 2021. PMID: 34335916 Free PMC article. Review.

4

Identification and Validation of Signature Genes and Potential Therapy Targets of Inflammatory Bowel Disease and Periodontitis.

Xiong Z, Fang Y, Lu S, Sun Q, Huang J. Xiong Z, et al. Among authors: lu s. J Inflamm Res. 2023 Sep 28;16:4317-4330. doi: 10.2147/JIR.S426004. eCollection 2023. J Inflamm Res. 2023. PMID: 37795494 Free PMC article.

5

Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL.

Zhou W, Miao J, Cheng Z, Wang Z, Wang J, Guo H, Wang P, Lu S, Si L, Zhang Z, Dunmall LC, Liu Y, Lemoine NR, Wang Y. Zhou W, et al. Among authors: lu s. Mol Ther Oncolytics. 2023 Aug 18;30:216-226. doi: 10.1016/j.omto.2023.08.009. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37663131 Free PMC article.

6

Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.

Lu S, Ahmed T, Du P, Wang Y. Lu S, et al. Int J Mol Sci. 2017 Jun 5;18(6):1201. doi: 10.3390/ijms18061201. Int J Mol Sci. 2017. PMID: 28587243 Free PMC article. Review.

7

Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy.

Baleeiro RB, Dunmall LSC, Liu P, Lu S, Lone Y, Lemoine NR, Wang Y. Baleeiro RB, et al. Among authors: lu s. Front Immunol. 2022 May 26;13:902709. doi: 10.3389/fimmu.2022.902709. eCollection 2022. Front Immunol. 2022. PMID: 35720289 Free PMC article.

8

Establishing a rabbit model of perianal fistulizing Crohn's disease.

Lu SS, Liu WJ, Niu QY, Huo CY, Cheng YQ, Wang EJ, Li RN, Feng FF, Cheng YM, Liu R, Huang J. Lu SS, et al. World J Gastroenterol. 2022 Apr 21;28(15):1536-1547. doi: 10.3748/wjg.v28.i15.1536. World J Gastroenterol. 2022. PMID: 35582134 Free PMC article.

9

Non cancer causes of death after gallbladder cancer diagnosis: a population-based analysis.

Xia Y, Lu S, Huo C, Fan L, Lin M, Huang J. Xia Y, et al. Among authors: lu s. Sci Rep. 2023 Aug 23;13(1):13746. doi: 10.1038/s41598-023-40134-4. Sci Rep. 2023. PMID: 37612302 Free PMC article.

10

Exploring neural activity in inflammatory bowel diseases using functional connectivity and DKI-fMRI fusion.

Deng J, Sun J, Lu S, Yue K, Liu W, Shi H, Zou L. Deng J, et al. Among authors: lu s. Behav Brain Res. 2023 Apr 12;443:114325. doi: 10.1016/j.bbr.2023.114325. Epub 2023 Feb 2. Behav Brain Res. 2023. PMID: 36736668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year